Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency
- PMID: 24894771
- DOI: 10.1182/blood-2014-03-564286
Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency
Abstract
Accumulation of CD3(+) T-cell receptor (TCR)αβ(+)CD4(-)CD8(-) double-negative T cells (DNT) is a hallmark of autoimmune lymphoproliferative syndrome (ALPS). DNT origin and differentiation pathways remain controversial. Here we show that human ALPS DNT have features of terminally differentiated effector memory T cells reexpressing CD45RA(+) (TEMRA), but are CD27(+)CD28(+)KLRG1(-) and do not express the transcription factor T-bet. This unique phenotype was also detected among CD4(+) or CD8(+) ALPS TEMRA cells. T-cell receptor β deep sequencing revealed a significant fraction of shared CDR3 sequences between ALPS DNT and both CD4(+) and CD8(+)TEMRA cells. Moreover, in ALPS patients with a germ line FAS mutation and somatic loss of heterozygosity, in whom biallelic mutant cells can be tracked by absent Fas expression, Fas-negative T cells accumulated not only among DNT, but also among CD4(+) and CD8(+)TEMRA cells. These data indicate that in human Fas deficiency DNT cannot only derive from CD8(+), but also from CD4(+) T cells. Furthermore, defective Fas signaling leads to aberrant transcriptional programs and differentiation of subsets of CD4(+) and CD8(+) T cells. Accumulation of these cells before their double-negative state appears to be an important early event in the pathogenesis of lymphoproliferation in ALPS patients.
© 2014 by The American Society of Hematology.
Comment in
-
Live and let die at TEMRA.Blood. 2014 Aug 7;124(6):828-30. doi: 10.1182/blood-2014-06-581637. Blood. 2014. PMID: 25104859 Free PMC article.
Similar articles
-
Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.Blood. 2016 Jul 14;128(2):227-38. doi: 10.1182/blood-2015-11-685024. Epub 2016 Apr 20. Blood. 2016. PMID: 27099149 Clinical Trial.
-
Live and let die at TEMRA.Blood. 2014 Aug 7;124(6):828-30. doi: 10.1182/blood-2014-06-581637. Blood. 2014. PMID: 25104859 Free PMC article.
-
Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.Immunobiology. 2016 Jan;221(1):40-7. doi: 10.1016/j.imbio.2015.08.004. Epub 2015 Aug 17. Immunobiology. 2016. PMID: 26323380
-
Thymic functions and gene expression profile distinct double-negative cells from single positive cells in the autoimmune lymphoproliferative syndrome.Autoimmun Rev. 2012 Aug;11(10):723-30. doi: 10.1016/j.autrev.2012.01.002. Epub 2012 Jan 18. Autoimmun Rev. 2012. PMID: 22273982 Review.
-
ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.Ann Hematol. 2022 Mar;101(3):469-484. doi: 10.1007/s00277-022-04761-7. Epub 2022 Jan 20. Ann Hematol. 2022. PMID: 35059842 Free PMC article. Review.
Cited by
-
Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).J Clin Immunol. 2015 Oct;35(7):661-7. doi: 10.1007/s10875-015-0203-z. Epub 2015 Oct 9. J Clin Immunol. 2015. PMID: 26453583 Free PMC article.
-
Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study.Front Immunol. 2022 Aug 1;13:931821. doi: 10.3389/fimmu.2022.931821. eCollection 2022. Front Immunol. 2022. PMID: 35979348 Free PMC article.
-
Peripheral immune cell profiling of double-hit lymphoma by mass cytometry.BMC Cancer. 2023 Feb 23;23(1):184. doi: 10.1186/s12885-023-10657-0. BMC Cancer. 2023. PMID: 36823603 Free PMC article.
-
Stabilized β-Catenin Ameliorates ALPS-Like Symptoms of B6/lpr Mice.J Immunol Res. 2017;2017:3469108. doi: 10.1155/2017/3469108. Epub 2017 Nov 9. J Immunol Res. 2017. PMID: 29250557 Free PMC article.
-
CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.Front Immunol. 2022 Feb 10;13:816005. doi: 10.3389/fimmu.2022.816005. eCollection 2022. Front Immunol. 2022. PMID: 35222392 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous